Nigel Keen - Bioquell plc Insider

BIQLF -- USA Stock  

USD 6.28  0.88  16.30%

Mr. Nigel J. Keen is an Independent NonExecutive Chairman of the Board of Bioquell PLC. since 2009. He Joined the Board in March 2008 and was appointed Chairman in 2009. He gained a degree in Engineering from Cambridge University and also qualified as an accountant with Deloitte. He has pursued a career encompassing industry VC and banking. He is Chairman of Oxford Instruments Plc and Deltex Medical Group Plc.
Age: 63  Chairman Since 2009      
44 1264 835 835

Management Efficiency

The company has return on total asset (ROA) of 5.58 % which means that it generated profit of $5.58 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.64 % meaning that it generated $10.64 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and traded on OTC Market. It employs 220 people.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 220 people.

Bioquell plc Leadership Team

Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director window.location = "/error404.html";